The Indian company that acquires Merck Generics, the multinational drug maker's generics (non-patented) business, up for sale, will be able to compete against the top global players -- Teva, Ivax......
Sun Pharmaceutical on Wednesday said Ranbaxy will be delisted from the Indian bourses following the completion of their $4-billion merger. "Following the closure of this transaction, Ranbaxy will......
Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each departmentRanbaxy Laboratories has hired the Boston Consulting Group (BCG) and Mercer......
India's biggest drug maker, Ranbaxy, has acquired Biovel Lifesciences, a Bangalore-based biotech company making typhoid and influenza vaccines, for an undisclosed sum. With this, Ranbaxy would make......
"Ranbaxy is my fourth child," Bhai Mohan Singh would often tell friends. So fond was he of the company he had nurtured since 1947, that he spoke of it on a par with his three sons. It would be......